FitLife Brands, Inc. (FTLF) is an Omaha, Nebraska-based developer and marketer of branded nutritional supplements and wellness products, selling more than 500 items online and through retail channels under names such as MRC, MusclePharm and Irwin Naturals. Shares were trading at $6.70 on Monday morning, down $1.78, or 20.99%, from Friday's close of $8.48. The direction is clearly negative, and the move followed the company's pre-market release of third-quarter 2026 results that fell short of analyst expectations on both the top and bottom lines, with management flagging a soft consumer environment and channel-specific weakness.
The dominant driver was the quarterly print. Revenue of $25.62 million improved 9% from $23.49 million a year earlier, and net income rose to $1.57 million from $921,000. However, revenue landed roughly $1.7 million below the consensus estimate of about $27.3 million, and earnings of $0.19 per share missed the $0.24 expectation by a nickel. Gross margin expanded to 37.7% from 37.2%, and contribution as a percentage of revenue held at 31.5%, but adjusted EBITDA fell 13% to $3.28 million from $3.79 million.
Just as importantly for a company of roughly $63 million in market value, revenue slipped sequentially from $26.5 million in the second quarter. Four consecutive quarters clustered between $25.3 million and $26.5 million now read to investors as a plateau rather than a growth trajectory, which is a difficult narrative to sustain when the shares already carry a leveraged balance sheet.
Management commentary sharpened the negative reaction. Legacy FitLife revenue fell 24% to $12.6 million, with wholesale down 34% on lower sales to certain retail partners, primarily GNC, and online revenue down 18%, driven mainly by MRC on Amazon. Irwin Naturals contributed $13.0 million and set the offset, with Irwin and MusclePharm online sales reaching all-time highs, but the company conceded that a weak consumer backdrop is affecting all of its brands.
Cost pressure added a second layer of concern. Whey protein and fish oil are experiencing sharp increases tied to supply shortages; the company has locked in fixed-price fish oil supply covering the majority of its needs for roughly the next 12 months, but working-capital swings tied to those forward purchases pushed borrowings modestly higher during the quarter. A restructuring completed in the third quarter is expected to trim about $1.2 million of annual operating expense starting in the fourth quarter, though investors appear to be treating that as insufficient to offset the softer demand picture.
Volume was heavy. Roughly 9,200 shares had changed hands within the first hour of trading, already close to the stock's full-day average of about 11,900 shares, indicating conviction selling rather than a thin, headline-driven wobble. The decline also pushed the shares below the prior 52-week low of $7.66 set on October 29, a technical break that likely accelerated momentum-driven and stop-loss selling.
The move was overwhelmingly idiosyncratic. The Nasdaq Composite was down about 1.1% and the S&P 500 roughly 0.6% in early trading, with technology and semiconductor names under pressure ahead of Nvidia's earnings and the anticipated Anthropic IPO. A 21% decline is far beyond any plausible index or sector drag, and the direction was opposite to nothing in the broader tape — the weakness was concentrated entirely in this name.
On a scale where 0 means no meaningful news and a move that is routine for the stock, and 100 means transformative news paired with an extreme, rare price move, FTLF scores 76 out of 100. The verified news was moderately strong: a miss on both revenue and earnings, a 13% decline in adjusted EBITDA, and a sequential revenue step-down at a company with limited analyst coverage and a leveraged balance sheet. It was material, but not transformative.
The price reaction was the more extreme component. The 20.99% drop was roughly 11 times the stock's average absolute daily move of about 1.9% over the prior 60-plus sessions, and no session in that window produced a decline anywhere near this size — the largest was about 10%. With volume running well above its normal pace, the two factors combine into a high, though not maximum, score.
The immediate focus is today's investor conference call at 4:30 p.m. ET, where management is expected to detail channel trends, the shape of the restructuring savings, and inventory and debt plans. Investors will also watch whether the locked-in fish oil supply and other cost-of-goods initiatives support margins in the fourth quarter, and whether the GNC and MRC pressures stabilize or deepen.
Risks cut both ways. Adjusted EBITDA of $13.7 million on a trailing-12-month basis and roughly $37 million of net debt leave limited room for further demand erosion, and thin trading liquidity means the shares can overshoot in either direction. A constructive call and evidence of sequential stabilization could prompt a rebound; continued revenue decay would keep pressure on a stock already trading at its lowest level in more than a year.
Tickeron's Trending AI Robots page curates the strongest performers from a library of hundreds of AI trading bots covering thousands of tickers. Each bot differs by strategy, timeframe, performance metrics and the symbols it trades, and only those posting the best results under current market conditions earn a spot in this featured section. It is a practical starting point for traders looking to benchmark systematic strategies against today's volatility. Explore the page to see which bots are leading right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
FTLF broke above its upper Bollinger Band on November 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 36 similar instances where the stock broke above the upper band. In 30 of the 36 cases the stock fell afterwards. This puts the odds of success at 83%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for FTLF entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FTLF's RSI Oscillator exited the oversold zone, 22 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on November 12, 2026. You may want to consider a long position or call options on FTLF as a result. In 54 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for FTLF just turned positive on November 04, 2026. Looking at past instances where FTLF's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTLF advanced for three days, in 140 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.580) is normal, around the industry mean (6.914). P/E Ratio (11.896) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.922) is also within normal values, averaging (5.003).
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. FTLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FTLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified